↓ Skip to main content

Engineered exosomes as an in situ DC-primed vaccine to boost antitumor immunity in breast cancer

Overview of attention for article published in Molecular Cancer, February 2022
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (59th percentile)
  • Above-average Attention Score compared to outputs of the same age and source (55th percentile)

Mentioned by

twitter
5 X users

Citations

dimensions_citation
157 Dimensions

Readers on

mendeley
95 Mendeley